Sign in

CIK 0001404644

  • Non-accelerated filer
  • Smaller reporting company

Neurogene Inc.

Sign in to watch
Ticker
NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
980542593
Phone
+1 877-237-5020
Business address
535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
Former names
Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
  1. 3 Insider Initial Statement of Ownership
  2. 4 Derivatives Options or other derivatives
  3. 4 Option exercise Director acquired 592,650 shares (option exercise)
  4. 4 Open-market buy Director bought 2,285,342 shares at an average $0.64 ($1,463,487)
  5. 4 Open-market sale Interim CFO, Prin Acct Off sold 1,323 shares at $0.62 ($818)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market sale Former Chief Medical Officer sold 3,769 shares at $0.69 ($2,608)
  13. 4 Open-market sale Principal Accounting Officer sold 3,316 shares at $0.60 ($1,980)
  14. 4 Open-market sale Chief Medical Officer sold 14,380 shares at $0.60 ($8,588)
  15. 4 Open-market sale Principal Accounting Officer sold 1,655 shares at $0.99 ($1,641)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 4 of 15 · 287 filings